about
Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profilingSystems biology from virus to humansVirus-like particles as antigenic nanomaterials for inducing protective immune responses in the lungMultiBac turns sweetVirus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemicLessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsVirus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenzaInfluenza virus-like particles containing M2 induce broadly cross protective immunityVirus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in miceVirus like particle-based vaccines against emerging infectious disease viruses.Influenza virus neuraminidase (NA): a target for antivirals and vaccines.Cutaneous immunization: an evolving paradigm in influenza vaccinesCritical assessment of influenza VLP production in Sf9 and HEK293 expression systems.An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesNew strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Current cell-based influenza vaccine production technology as pandemic contingency.Microneedle and mucosal delivery of influenza vaccines.Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteinsChanges in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosisProtein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responsesContribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.Plant-derived virus-like particles as vaccinesEvaluation of protective efficacy induced by virus-like particles containing a Trichinella spiralis excretory-secretory (ES) protein in miceMucosal adjuvants for influenza virus-like particle vaccine.Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.Swine influenza vaccines: current status and future perspectives.Virus-like particles in vaccine development.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.Developments in virus-like particle-based vaccines for infectious diseases and cancer.
P2860
Q21131780-E4E5331B-0685-4C1B-B955-4AE22989D470Q26798272-DDE8220C-34BC-4B94-B66E-054A5C4E91CEQ26825031-6C0F0F90-87EF-472B-8788-B776A62E46FDQ26830759-EA6F313B-99DC-40BD-BF0B-3A2F12A4D07AQ26860373-E601222D-550D-4811-A84C-DD2ADFE78311Q27013018-69FFB731-B69C-4B9A-85AE-B7603CFBDC73Q28741801-0CF84982-DFEB-484D-88A5-C9D5D853FD72Q28743472-3CC9E37E-647D-4DA9-AD3D-5D158971E862Q28748950-6F47794A-D339-4D47-857D-520489674725Q30249025-994A7F74-0FC2-4EDF-B747-1683C1AF91E8Q30249879-BD34D6EB-441B-45D9-B44D-F31BDAC41B9CQ30358895-2332463E-3AAB-4824-BB25-80CE7E1B6716Q30374733-8AFC7844-2D15-44A6-96C0-7BF5EDBBA602Q30377023-77360E35-5E3A-44F9-831D-37C6E0DCC813Q30383973-9D189D4B-1A56-469D-81B4-65DE9384435EQ30387030-19891BFF-75E8-4C67-A3E9-8DD8CA367E01Q30407424-44DC54E3-C5A1-4514-A460-31A8B23118D9Q30414391-86671FE5-041C-4028-957C-C1F126BFF7A7Q30418015-C7BE7143-534A-4A46-B14C-DD398BAFCFE4Q30418285-B9EC6393-0D00-4131-9E2E-BF761F3A09C1Q30419591-B1EA7581-AA70-4B31-BC5D-33298AAFDBEFQ33677863-CE3EF1AD-A4A3-4820-BCB3-CFF8C0A0D294Q33682225-35BB6E84-2D0F-49FF-B90D-4625FC49E56DQ34416974-454E262C-26BD-4B3C-A1E0-7DB8C0053D0CQ34791209-DCA531BF-8CCF-4231-A7CB-10DAFFCF2857Q35151690-E55C630E-1D32-433D-B8E0-BDF4860C617CQ35188476-89A156A0-DAD1-41E9-A84D-7BE92C7AED09Q35300720-9BF0EAB1-ECE2-4A49-ADC0-0690B01A9093Q35883016-0A2C084B-2142-4EFE-8A62-0E9CA69FA9C1Q36075789-AE7ADB9D-F836-4531-883A-9F8D6E3385B5Q36849574-6E6D7E59-D0E4-4519-BB14-577F22EA2AE6Q36888029-C9E21946-C358-4E9F-97D4-A64BDEAC561CQ37064556-DC6626CD-FDAD-4C74-A639-EBD7C08C4FCFQ37404044-FC16BD04-579B-480A-9A13-E3238EB2C32AQ37469592-FF67A199-2259-43E8-9606-DD32CF3DDFA4Q37749889-A81E03EE-1EA6-49EE-9508-44D2BE2AA98BQ37798008-745147B8-3477-4A5A-A11E-7BDB86494851Q37834097-793BFACA-48A9-4929-92FB-7A6F0B72FAE4Q37900305-7F2F176F-1D56-460D-A763-BC482D660217Q37951525-893B7300-1799-4E1C-8A83-7D81D7128387
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Influenza vaccines based on virus-like particles
@ast
Influenza vaccines based on virus-like particles
@en
type
label
Influenza vaccines based on virus-like particles
@ast
Influenza vaccines based on virus-like particles
@en
prefLabel
Influenza vaccines based on virus-like particles
@ast
Influenza vaccines based on virus-like particles
@en
P2093
P2860
P1433
P1476
Influenza vaccines based on virus-like particles
@en
P2093
Fu-Shi Quan
Jae-Min Song
Sang-Moo Kang
P2860
P304
P356
10.1016/J.VIRUSRES.2009.04.005
P577
2009-04-15T00:00:00Z